Live feed
Filing
SC 13D/A
SC 13D/A0001437749-24-004592·Bhat Laxminarayan
Schedule 13D ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Security class unavailable · CUSIP: 76152G100
Event date: 2023-11-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,885,678
- Percent of class
- 10.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-24-004592
- Form type
- SC 13D/A
- Filer
- Bhat Laxminarayan
- CIK
- CIK 1818245
- Filed
- Feb 16, 2024
- Reporting period
- Nov 20, 2023
- Description
- Schedule 13D beneficial ownership